Advertisement
Screener

Quoin Pharmaceuticals Ltd. (QNRX) Additional Paid in Capital

1.3 / 5 stars · 10/39 Roast Me

Quoin Pharmaceuticals Ltd. Additional Paid in Capital

Quoin Pharmaceuticals Ltd. (QNRX) had Additional Paid in Capital of ILS 127.00 million as of 2021-06-30, per its 6-K filed 2021-08-24.

Discontinued › Notes

ifrs-full:AdditionalPaidinCapital · last filed 2021-08-24

  • 2021-06-30: Additional Paid in Capital 127.00M ILS.
  • 2020-12-31: Additional Paid in Capital 126.84M ILS.
  • 2020-06-30: Additional Paid in Capital 126.84M ILS.
  • 2019-12-31: Additional Paid in Capital 108.60M ILS.

ILS

Period endAdditional Paid in Capital
2021-06-30127.00M ILS
6-K · filed 2021-08-24
2020-12-31126.84M ILS
6-K · filed 2021-08-24
2020-06-30126.84M ILS
6-K/A · filed 2021-02-11
2019-12-31108.60M ILS
20-F · filed 2021-03-29
2019-06-30108.31M ILS
6-K · filed 2019-08-13
2018-12-3195.08M ILS
6-K · filed 2019-08-13
2018-06-3094.65M ILS
6-K · filed 2018-08-09
2017-12-3182.84M ILS
20-F · filed 2019-03-18
2016-12-3167.41M ILS
20-F · filed 2018-03-19

USD

Period endAdditional Paid in Capital
2021-06-30$38.95M
6-K · filed 2021-08-24
2020-12-31$39.45M
20-F · filed 2021-03-29
2018-06-30$25.93M
6-K · filed 2018-08-09
2017-12-31$23.89M
20-F · filed 2018-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05